Skip to main content
Clinical Trials/EUCTR2009-012667-34-NO
EUCTR2009-012667-34-NOActive, not recruitingPhase 1

BRONCHIOLITIS, OPTIMAL TREATMENT IN INFANTS AND PROGNOSIS

Oslo University Hospital - Ullevål0 sitesStarted: November 16, 2009Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Phase 1
Status
Active, not recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
All

Inclusion Criteria

  • Bronchiolitis as defined on clinical criteria by Court (nasal flaring, tachypnoea, dyspnoea, chest recessions, crepitations and sometimes sibiliations.). Clinical score of 4 or more (see amendment). Age <7 months.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

Exclusion Criteria

  • Significant cardiac, previous severe or persisting (>4 weeks) respiratory disease, neurological or other disease that may significantly influence the outcomes, including Down’s syndrome. Prematurity per se is not a reason for exclusion. One single previous mild-moderate episode suspect of bronchial obstruction is not an exclusion criterion.

Investigators

Sponsor
Oslo University Hospital - Ullevål

Similar Trials